Dickkopf 4 (DKK4) Acts on Wnt/β-catenin Pathway by Influencing β-catenin in Hepatocellular Carcinoma

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2012 Jan 18

PMID 22249261

Citations 26

Authors

S Fatima

N P Lee

F H Tsang

F T Kolligs

I O L Ng

R T P Poon

S T Fan

J M Luk

Affiliations

Soon will be listed here.

Abstract

Deregulation of Wnt/β-catenin pathway is a hallmark of major gastrointestinal cancers including hepatocellular carcinoma (HCC). The oncogenic role of β-catenin is well defined but reasons for its accumulation in HCC remain unclear. Dickkopf 4 (DKK4) acts as a negative regulator of Wnt/β-catenin pathway but its functional role in liver carcinogenesis has not been studied. We investigated the role of DKK4 in β-catenin regulation in HCC. Reduced expression of DKK4 was found in 47% (38/81) of HCC, as measured by quantitative real time PCR. Ectopic expression of DKK4 in two HCC cell lines, PLC/PRF/5 (PLC) and MHCC97L (97L), attenuated β-catenin responsive luciferase activity, and decreased both β-catenin and cyclin D1 protein levels. To study the effect of DKK4 on cell growth and tumourigenicity, two stable HCC cell lines were established from PLC and 97L cells. Functional assays demonstrated that overexpression of DKK4 hampered cell proliferation, reduced colony formation and retarded cell migration. When DKK4-expressing 97L stable cells were used to induce tumour xenografts in nude mice (n=8), reduction in tumour sizes was observed (P=0.027). Furthermore, immunohistochemical studies showed that decreased expression of DKK4 was associated with β-catenin accumulation in HCC tissues. Additionally, inhibition of the proteasome using specific inhibitor in DKK4-expressing 97L stable cells masked the effect of β-catenin. Our findings suggest a potential tumour suppressive role of DKK4 as well as that of an important regulator of HCC.

Citing Articles

Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma.

Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J Curr Oncol. 2025; 32(1).

PMID: 39851951 PMC: 11763369. DOI: 10.3390/curroncol32010035.

The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.

Lei Z, Teng Q, Koya J, Liu Y, Chen Z, Zeng L Front Immunol. 2024; 15:1417201.

PMID: 39403386 PMC: 11471544. DOI: 10.3389/fimmu.2024.1417201.

Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis.

Li X, Chen Y, Lu R, Hu M, Gu L, Huang Q Oncogene. 2024; 43(20):1506-1521.

PMID: 38519641 PMC: 11090838. DOI: 10.1038/s41388-024-03008-1.

Dickkopf 4 Alone and in Combination with Leucyl-tRNA Synthetase as a Good Prognostic Biomarker for Human Colorectal Cancer.

Park S, Cho J, Han S, Kim Y, Pak M, Roh M Biomed Res Int. 2023; 2023:9057735.

PMID: 37096225 PMC: 10122595. DOI: 10.1155/2023/9057735.

Wnt antagonist as therapeutic targets in ovarian cancer.

Y K, Perumalsamy N, Warrier S, Perumalsamy L, Dharmarajan A Int J Biochem Cell Biol. 2022; 145:106191.

PMID: 35272015 PMC: 7616886. DOI: 10.1016/j.biocel.2022.106191.

References

Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martinez-Anso E . Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 2009; 69(17):6951-9. DOI: 10.1158/0008-5472.CAN-09-0541. View

Matsui A, Yamaguchi T, Maekawa S, Miyazaki C, Takano S, Uetake T . DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer. Cancer Sci. 2009; 100(10):1923-30. PMC: 11159872. DOI: 10.1111/j.1349-7006.2009.01272.x. View

Nejak-Bowen K, Monga S . Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol. 2010; 21(1):44-58. PMC: 3050081. DOI: 10.1016/j.semcancer.2010.12.010. View

Hirata H, Hinoda Y, Majid S, Chen Y, Zaman M, Ueno K . DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma. Cancer. 2011; 117(8):1649-60. PMC: 5871344. DOI: 10.1002/cncr.25666. View

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

Liu A, Poon R, Luk J . MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 2010; 394(3):623-7. DOI: 10.1016/j.bbrc.2010.03.036. View

Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler B . Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 2002; 417(6889):664-7. DOI: 10.1038/nature756. View

Hao K, Luk J, Lee N, Mao M, Zhang C, Ferguson M . Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer. 2009; 9:389. PMC: 2785835. DOI: 10.1186/1471-2407-9-389. View

Zhang L, Qin L, Ma Z, Ye S, Liu Y, Ye Q . Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. J Cancer Res Clin Oncol. 2003; 129(5):279-86. DOI: 10.1007/s00432-002-0407-5. View

10.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K . Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res. 2009; 15(18):5678-87. DOI: 10.1158/1078-0432.CCR-09-0558. View

11.

Wiesman K, Wei L, Baughman C, Russo J, Gray M, Castellot J . CCN5, a secreted protein, localizes to the nucleus. J Cell Commun Signal. 2010; 4(2):91-8. PMC: 2876239. DOI: 10.1007/s12079-010-0087-x. View

12.

MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View

13.

Liao C, Yeh C, Huang Y, Wu S, Chi H, Tsai M . Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Hepatology. 2011; 55(3):910-20. DOI: 10.1002/hep.24740. View

14.

Orford K, Crockett C, Jensen J, Weissman A, Byers S . Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem. 1997; 272(40):24735-8. DOI: 10.1074/jbc.272.40.24735. View

15.

Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S . Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis. 2007; 28(12):2459-66. DOI: 10.1093/carcin/bgm178. View

16.

Kemp W, Pianko S, Nguyen S, Bailey M, Roberts S . Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol. 2005; 20(6):873-81. DOI: 10.1111/j.1440-1746.2005.03844.x. View

17.

Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y . DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene. 2004; 23(52):8520-6. DOI: 10.1038/sj.onc.1207892. View

18.

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

19.

Gonzalez F . Role of beta-catenin in the adult liver. Hepatology. 2006; 43(4):650-3. PMC: 1440290. DOI: 10.1002/hep.21154. View

20.

Lu W, Lee N, Kaul S, Lan F, Poon R, Wadhwa R . Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int J Cancer. 2010; 129(8):1806-14. DOI: 10.1002/ijc.25857. View